Psyence Group Inc. announced that it has appointed Dr. Neil Maresky as Chief Executive Officer. Dr. Maresky joins Psyence after just having completed more than a decade at AstraZeneca Canada, most recently as Vice President of Scientific Affairs. Dr. Maresky brings more than 20 years of enterprise leadership and biopharmaceutical expertise to this role. He will oversee the strategy and operations of Psyence and ensure the delivery of key metrics of the Psyence portfolio including Psyence Production, Therapeutics, Experience and Function. Dr. Maresky, having completed more than a decade at AstraZeneca Canada, most recently as Vice President of Scientific Affairs, is a South African trained doctor.